BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17635153)

  • 1. Cell-penetrating-peptide-mediated siRNA lung delivery.
    Moschos SA; Williams AE; Lindsay MA
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):807-10. PubMed ID: 17635153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.
    Moschos SA; Jones SW; Perry MM; Williams AE; Erjefalt JS; Turner JJ; Barnes PJ; Sproat BS; Gait MJ; Lindsay MA
    Bioconjug Chem; 2007; 18(5):1450-9. PubMed ID: 17711319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
    Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
    Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating-peptide-based delivery of oligonucleotides: an overview.
    Abes R; Arzumanov AA; Moulton HM; Abes S; Ivanova GD; Iversen PL; Gait MJ; Lebleu B
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):775-9. PubMed ID: 17635146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptides in drug development: enabling intracellular targets.
    Chen L; Harrison SD
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):821-5. PubMed ID: 17635156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
    Furukawa K; Tanaka M; Oba M
    Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of cell-penetrating peptides in regulation of gene expression.
    Järver P; Langel K; El-Andaloussi S; Langel U
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):770-4. PubMed ID: 17635145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
    Li H; Tsui TY; Ma W
    Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Versatility of cell-penetrating peptides for intracellular delivery of siRNA.
    Singh T; Murthy ASN; Yang HJ; Im J
    Drug Deliv; 2018 Nov; 25(1):1996-2006. PubMed ID: 30799658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
    Turner JJ; Jones S; Fabani MM; Ivanova G; Arzumanov AA; Gait MJ
    Blood Cells Mol Dis; 2007; 38(1):1-7. PubMed ID: 17113327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
    Uchida T; Kanazawa T; Takashima Y; Okada H
    Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptides for siRNA delivery to glioblastomas.
    Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
    Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
    Kurrikoff K; Gestin M; Langel Ü
    Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
    Meade BR; Dowdy SF
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic cell-penetrating peptides as vehicles for siRNA delivery.
    Beloor J; Zeller S; Choi CS; Lee SK; Kumar P
    Ther Deliv; 2015; 6(4):491-507. PubMed ID: 25996046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing.
    Baoum A; Ovcharenko D; Berkland C
    Int J Pharm; 2012 May; 427(1):134-42. PubMed ID: 21856394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTD/CPP peptide-mediated delivery of siRNAs.
    Presente A; Dowdy SF
    Curr Pharm Des; 2013; 19(16):2943-7. PubMed ID: 23140460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The many futures for cell-penetrating peptides: how soon is now?
    Howl J; Nicholl ID; Jones S
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):767-9. PubMed ID: 17635144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.